losartan and lisinopril

losartan has been researched along with lisinopril in 133 studies

Research

Studies (133)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	32 (24.06)	18.2507
2000's	53 (39.85)	29.6817
2010's	42 (31.58)	24.3611
2020's	6 (4.51)	2.80

Authors

Authors	Studies
Abbenante, G; Fairlie, DP; Leung, D	1
Funakoshi, J; Kakumoto, M; Okumura, K; Sakaeda, T; Takara, K; Tanigawara, Y	1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Lombardo, F; Obach, RS; Waters, NJ	1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV	1
Avdeef, A; Tam, KY	1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ	1
Ekins, S; Williams, AJ; Xu, JJ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M	1
Dean, RH; Ferrario, CM; Fuller, SB; Nakamoto, H; Robaczewski, DL; Winicov, E	1
Auch-Schwelk, W; Duske, E; Fleck, E; Hess, B; Hildebrandt, AG; Klein, U; Regitz-Zagrosek, V; Steffen, C	1
Caputo, L; Lévy, BI; Tedgui, A	1
Aubert, JF; Brunner, HR; Niederberger, M; Nussberger, J; Waeber, B	1
el Amrani, AI; Gonzales, MF; Menard, J; Michel, JB	1
Brunner, H; Dobbins, TW; Faison, EP; Irwin, R; Karlberg, BE; Lacourcière, Y; Nelson, EB; Ramsay, LE; Snavely, DB	1
Devineni, VR; Henegar, JR; Janicki, JS; Kabour, A	1
Sun, Y; Weber, KT	1
Martinez-Maldonado, M; Pimentel, JL; Wang, S	1
Faison, EP; Lacourcière, Y; Lefebvre, J; Nakhle, G; Nelson, EB; Snavely, DB	1
Brosnihan, KB; Ferrario, CM; Ganten, D; Kumagai, H; Moriguchi, A	1
Averill, DB; Ferrario, CM; Khosla, MC; Kumagai, H	1
Luo, C; Martinez-Maldonado, M; Pimentel, JL; Wang, S; Wilcox, JN	1
Ramsay, LE; Yeo, WW	2
Gabb, GM	1
Chan, P; Huang, TY; Ko, JT; Lee, YS; Lin, TS; Tomlinson, B	1
Ganjam, VK; Ramires, FJ; Sun, Y; Weber, KT; Zhou, G	1
Albrecht, D; Ganten, D; Henklein, P	1
Chappell, MC; Ferrario, CM; Iyer, SN	1
Averill, DB; Chappell, MC; Diz, DI; Ferrario, CM; Iyer, SN	1
Campbell, SE; Dhalla, AK; Kandala, JC; Katwa, LC; Sun, Y; Tyagi, SC; Weber, KT	1
Chappell, MC; Ferrario, CM; Ganten, D; Iyer, SN; Yamada, K	1
De Plaen, JF; Goffin, E; Lejuste, P; Pochet, JM	1
Corradi, L; Fogari, R; Lazzari, P; Lusardi, P; Mugellini, A; Zoppi, A	1
Mackay, FJ; Mann, RD; Pearce, GL	1
Brosnihan, KB; Chappell, MC; Ferrario, CM; Fukuhara, M; Iyer, SN; Yamada, K	1
Conigliaro, RL; Gleason, PP	2
Bellissant, E; Durand-Castel, X; Goineau, S; Guillo, P; Pape, D	1
MacGregor, GA; Missouris, CG; Morton, JJ; Patel, SJ	1
Damme, U; Daniel, WG; Garlichs, CD; Mügge, A; Plötze, K; Schmeisser, A; Zhang, H	1
de Paz, S; Domínguez, AR; Iglesias, A; Martín, AB	1
Andersen, S; Bos, H; De Jong, PE; De Zeeuw, D; Navis, G; Parving, HH; Rossing, P	1
Chappell, MC; Diz, DI; Ferrario, CM; Iyer, SN; Yamada, K	1
Amaral, SL; Greene, AS; Linderman, JR; Morse, MM	1
Borhani, M; Curci, JA; Kelley, BJ; Liao, S; Miralles, M; Thompson, RW	1
Agarwal, R	1
Baibas, NM; Kalkana, CB; Mountokalakis, TD; Roussias, LG; Skeva, II; Stergiou, GS	1
Agabiti-Rosei, E; Rizzoni, D	1
Agarwal, R; Dunn, SR; Sharma, K; Siva, S	1
Achard, JM; Allard, J; Dalmay, F; Fournier, A; Mazouz, H; Pesteil, F	1
Cappello, D; Francesco, L; Morale, W; Puliatti, C; Puliatti, D; Valvo, C; Veroux, M; Veroux, P	1
de Jong, PE; de Zeeuw, D; Henning, RH; Laverman, GD; Navis, G	1
Akinboboye, OO; Bergmann, SR; Chou, RL	1
Baibas, NM; Efstathiou, SP; Kalkana, CB; Mountokalakis, TD; Skeva, II; Stergiou, GS	1
Alhenc-Gelas, F; Chollet, C; Helou, CM; Marchetti, J; Rajerison, R	1
Goto, O; Imoto, T; Ishida, A; Miyoshi, M; Nagata, K; Watanabe, T	1
Parati, G; Radauceanu, A; Zannad, F	1
Baibas, NM; Efstathiou, SP; Mountokalakis, TD; Roussias, LG; Skeva, II; Stergiou, GS	1
Buikema, H; de Zeeuw, D; Gschwend, S; Henning, RH; Pinto, YM; van Gilst, WH	1
Goto, O; Imoto, T; Matsumoto, K; Miyoshi, M; Shimizu, H; Watanabe, T	1
Frank, R; Gauthier, BG; Ramek, J; Stoll, ML; Trachtman, H; Vergara, M	1
Chiang, HT; Lin, SL; Liu, CP; Wu, SC	1
Dworkin, L; Yango, A; Zanabli, AR	1
Sarlos, S; Wilkinson-Berka, JL	1
Komuro, I; Kuwabara, Y	1
de Paiva, SA; Epifanio, HB; Inoue, RM; Matsubara, BB; Matsubara, LS; Zornoff, LA	1
Aragon, FF; Cicogna, AC; Cordaro, FR; Gonçalves, G; Okoshi, K; Okoshi, MP; Padovani, CR; Ribeiro, HB; Zornoff, LA	1
Averill, DB; Brosnihan, KB; Chappell, MC; Diz, DI; Ferrario, CM; Gallagher, PE; Jessup, J; Tallant, EA	1
Higashiura, K; Shimamoto, K	1
Luño, J	1
Dullaart, RP; Groen, AK; Laverman, GD; Navis, G; van Tol, A; Vogt, L	1
Ann Tallant, E; Averill, DB; Brosnihan, KB; Chappell, MC; Ferrario, CM; Gallagher, PE; Jessup, J; Smith, RD	1
Allison, AC; Eugui, EM	1
Butorov, IV; Butorov, SI; Verbitskiĭ, ON	1
Imoto, T; Miyoshi, M; Sato, K; Shimizu, H; Taniguchi, M; Watanabe, K; Watanabe, T	1
Averill, DB; Brosnihan, KB; Chappell, MC; Ferrario, CM; Gallagher, PE; Jessup, JA; Tallant, EA	1
Hanevold, CD	1
Miyagi, R; Okamoto, H; Sugiyama, K; Yayama, K	1
Apostolakis, S; Baritaki, S; Kochiadakis, GE; Krambovitis, E; Spandidos, DA; Vlata, Z	1
Abdallah, HM; El-Batran, SA; El-Demerdash, E; Salam, OM; Shaffie, NM	1
Nayak, V; Patil, PA	1
Celiński, K; Czechowska, G; Korobowicz, E; Korolczuk, A; Madro, A; Prozorow-Król, B; Słomka, M	1
Larczyński, W; Renke, M; Rutkowski, B; Rutkowski, P; Tylicki, L; Zietkiewicz, M	1
Brophy, M; Duckworth, W; Emanuele, N; Fried, LF; Huang, GD; McCullough, PA; O'Connor, T; Palevsky, PM; Peduzzi, P; Seliger, S; Warren, SR; Zhang, JH	1
Chappell, MC; Groban, L; Jessup, JA; Westwood, BM	1
Devereux, RB; Fleg, JL; Galloway, JM; Henderson, JA; Howard, BV; Howard, WJ; Lee, E; Ratner, R; Russell, M; Silverman, A; Sorkin, J; Stylianou, M; Umans, JG; Weir, MR; Wilson, C; Yeh, F	1
Emel'ianova, OI; Erokhina, IL; Kazachenko, AA; Kulikov, AN; Okovityĭ, SV	1
Adams-Huet, B; Mehdi, UF; Raskin, P; Toto, RD; Vega, GL	1
Filiopoulos, V; Georgoulias, C; Kosmadakis, G; Michail, S; Tentolouris, N	1
Badillo, FH; González-Cortazar, M; Herrera-Ruiz, M; Jiménez-Ferrer, E; Tortoriello, J	1
Furuse, Y; Hisatome, I; Ishida, K; Kaetsu, Y; Kato, M; Kinugasa, Y; Mizuta, E; Ogino, K; Shigemasa, C; Sugihara, S; Yanagihara, K	1
Abraham, NG; Cheng, J; Falck, JR; Goli, M; Gotlinger, K; Inoue, K; Schwartzman, ML; Sodhi, K; Wu, CC	1
Ramalho, FS; Ramalho, LZ; Silva, Rde B	1
Gassman, J; Gipson, D; Greene, T; Joy, M; Pinsk, M; Savin, V; Somers, M; Trachtman, H; Vento, S; Wickman, L	1
Butorov, IV; Gonchar, VI; Nekula, GI; Tofan, EF	1
Bahde, R; Bandi, S; Bhargava, KK; Gupta, S; Kapoor, S; Palestro, CJ	1
Lin, Y; Stapff, M; Weiss, RJ	1
Bongianni, F; Cinelli, E; Evangelista, S; Mutolo, D; Pantaleo, T	1
Bakris, G; Briasoulis, A; Flynn, C; Kalaitzidis, R; Lazich, I; Oliva, R; Schlaffer, C	1
de Zeeuw, D	1
Brophy, M; Conner, TA; Duckworth, W; Emanuele, N; Fried, LF; Guarino, P; Leehey, DJ; McCullough, PA; O'Connor, T; Palevsky, PM; Peduzzi, P; Reilly, RF; Seliger, SL; Warren, SR; Watnick, S; Zhang, JH	1
Adams-Huet, B; Molina, C; Nguyen, M; Toto, RD; Van Buren, PN	1
Fried, LF; Seliger, SL	1
Janssen, PM; Murray, JD; Rafael-Fortney, JA; Raman, SV; Rastogi, N; Schill, KE; Schultz, EJ; Tran, T	1
Emanuele, N; Fried, LF; Zhang, JH	1
Fernández Juárez, G; Luño, J; Quiroga, B	1
Izumi, Y; Kawahara, K; Nonoguchi, H	1
Best, M; de Wever, J; Smulders, Y	1
Doumas, M; Lazaridis, A; Nikolaidou, B	1
Steurer, J	1
Jeffers, BW; Wang, JG; Yan, P	1
Busnardo, C; Correa, FM; Tavares, RF	1
Blaine, J; Faubel, S; Hung, KW	1
Ferastraoaru, D; Jariwala, S; Rosenstreich, D	1
Birnie, KM; Fajt, ML; Ghobrial, II; Petrov, AA; Thalanayar, MP	1
Appel, G; Bay, RC; Carter, B; Cattran, D; Cerda, J; Fervenza, FC; Fischer, D; Gipson, D; Hernandez, G; Hogg, RJ; Hurley, RM; Jennette, JC; Jung, B; Kumar, S; Sibley, R; Wyatt, RJ	1
Emanuele, NV; Fried, LF; Guarino, P; Leehey, DJ; Palevsky, PM; Reilly, RF; Whaley-Connell, A; Zhang, JH	1
Brzozowski, T; Konturek, SJ; Korbut, R; Kwiecien, S; Madej, J; Olszanecki, R; Pajdo, R; Pawlik, MW; Ptak-Belowska, A; Suski, M; Targosz, A	1
Emanuele, N; Fried, LF; Palevsky, PM; Seliger, SL; Zhang, JH	1
Augusto, MJ; Elias Júnior, J; Parreira, NA; Prado, CM; Ramalho, FS; Ramalho, LNZ; Rodrigues, V; Silva, DM	1
Hamasaki, Y; Hataya, H; Honda, M; Iijima, K; Ishikura, K; Ito, S; Kaito, H; Kamei, K; Nakamura, H; Nakanishi, K; Nozu, K; Ohashi, Y; Saito-Oba, M; Sako, M; Shima, Y; Tanaka, R; Yoshikawa, N	1
Bourke, JP; Bueser, T; Quinlivan, R	1
Gutiérrez, E	1
Hebibovic, S; Jatic, Z; Rustempasic, E; Skopljak, A; Sukalo, A; Valjevac, A	1
Glick, A; Johnson, C; Sista, V	1
Botts, SR; Delate, T; Derington, CG; Kao, DP; King, JB; Kroehl, M; Trinkley, KE	1
Campos, SK; Churko, JM; Gregorio, CC; Iwanski, J; Jena, L; Kazmouz, SG; Kazui, T; Khanna, M; Konhilas, JP; Li, S; Lick, S; Nikolich-Žugich, J; Perez-Miller, S; Salem, TT; Stansfield, B; Uhrlaub, JL	1
Ankrah, D; Hollingworth, SA; Okeke, CC; Ruiz, F; Thacher, E; Uzochukwu, BSC	1
Becker, Y; Stock, C	1

Reviews

9 review(s) available for losartan and lisinopril

Article	Year
Protease inhibitors: current status and future prospects. Journal of medicinal chemistry, 2000, Feb-10, Volume: 43, Issue:3 Topics: Animals; Aspartic Acid Endopeptidases; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Humans; Metalloendopeptidases; Models, Molecular; Protease Inhibitors; Serine Endopeptidases; Serine Proteinase Inhibitors	2000
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Trough-to-peak ratio, smoothness index and morning-to-evening ratio: why, which and when? Journal of hypertension, 2003, Volume: 21, Issue:5 Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; Diastole; Humans; Lisinopril; Losartan; Systole	2003
[Ace inhibitors and angiotensin II receptor antagonists for therapy of chronic heart failure]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 2005, Feb-10, Volume: 94, Issue:2 Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Clinical Trials as Topic; Enalapril; Heart Failure; Humans; Indoles; Lisinopril; Losartan; Renin-Angiotensin System; Tetrazoles; Valine; Valsartan	2005
[Progress on the drug therapy for diabetic microangiopathies: RA system inhibitor]. Nihon rinsho. Japanese journal of clinical medicine, 2005, Volume: 63 Suppl 6 Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Clinical Trials as Topic; Diabetic Angiopathies; Humans; Hypertension; Lisinopril; Losartan; Renin-Angiotensin System; Risk	2005
[Renin-angiotensin system in diabetic nephropathy]. Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2005, Volume: 25 Suppl 2 Topics: Albuminuria; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Glucose; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Drug Therapy, Combination; Homeostasis; Humans; Lisinopril; Losartan; Meta-Analysis as Topic; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Risk Factors; Telmisartan	2005
Mechanisms of action of mycophenolate mofetil in preventing acute and chronic allograft rejection. Transplantation, 2005, Oct-15, Volume: 80, Issue:2 Suppl Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; B-Lymphocytes; Dendritic Cells; Drug Synergism; Ganciclovir; Graft Rejection; Humans; Lisinopril; Losartan; Monocytes; Mycophenolic Acid; Neutrophil Infiltration; Nitric Oxide; Prodrugs; T-Lymphocytes	2005
Effects of amlodipine and other classes of antihypertensive drugs on long-term blood pressure variability: evidence from randomized controlled trials. Journal of the American Society of Hypertension : JASH, 2014, Volume: 8, Issue:5 Topics: Amlodipine; Antihypertensive Agents; Atenolol; Blood Pressure; Cardiovascular Diseases; Chlorthalidone; Enalapril; Humans; Hypertension; Lisinopril; Losartan; Randomized Controlled Trials as Topic	2014
Interventions for preventing and treating cardiac complications in Duchenne and Becker muscular dystrophy and X-linked dilated cardiomyopathy. The Cochrane database of systematic reviews, 2018, Oct-16, Volume: 10 Topics: Adolescent; Adult; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cardiomyopathies; Cardiomyopathy, Dilated; Cardiovascular Agents; Child; Disease Progression; Eplerenone; Human Growth Hormone; Humans; Lisinopril; Losartan; Male; Muscular Dystrophy, Duchenne; Non-Randomized Controlled Trials as Topic; Perindopril; Placebos; Randomized Controlled Trials as Topic; Stroke Volume; Ubiquinone; Young Adult	2018

Trials

28 trial(s) available for losartan and lisinopril

Article	Year
Effects of modulators of the renin-angiotensin-aldosterone system on cough. Losartan Cough Study Group. Journal of hypertension, 1994, Volume: 12, Issue:12 Topics: Adult; Aged; Angiotensin Receptor Antagonists; Biphenyl Compounds; Cough; Double-Blind Method; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Lisinopril; Losartan; Male; Middle Aged; Prospective Studies; Renin-Angiotensin System; Tetrazoles	1994
Association between cough and angiotensin converting enzyme inhibitors versus angiotensin II antagonists: the design of a prospective, controlled study. Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 1994, Volume: 12, Issue:2 Topics: Adult; Angiotensin II; Antihypertensive Agents; Biphenyl Compounds; Cough; Double-Blind Method; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Lisinopril; Losartan; Male; Prospective Studies; Research Design; Surveys and Questionnaires; Tetrazoles	1994
ACE inhibitors, angiotensin II antagonists and cough. The Losartan Cough Study Group. Journal of human hypertension, 1995, Volume: 9 Suppl 5 Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biphenyl Compounds; Cough; Double-Blind Method; Female; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Lisinopril; Losartan; Male; Middle Aged; Surveys and Questionnaires; Tetrazoles	1995
Double-blind comparison of losartan, lisinopril, and metolazone in elderly hypertensive patients with previous angiotensin-converting enzyme inhibitor-induced cough. Journal of clinical pharmacology, 1997, Volume: 37, Issue:3 Topics: Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzothiadiazines; Biphenyl Compounds; Cough; Diuretics; Double-Blind Method; Female; Humans; Hypertension; Imidazoles; Lisinopril; Losartan; Male; Metolazone; Sodium Chloride Symporter Inhibitors; Surveys and Questionnaires; Tetrazoles	1997
Comparative effects of lisinopril and losartan on insulin sensitivity in the treatment of non diabetic hypertensive patients. British journal of clinical pharmacology, 1998, Volume: 46, Issue:5 Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Glucose; Blood Pressure; Body Weight; Cross-Over Studies; Double-Blind Method; Female; Humans; Hypertension; Insulin; Insulin Resistance; Lipid Metabolism; Lisinopril; Losartan; Male; Middle Aged	1998
Add-on angiotensin receptor blockade with maximized ACE inhibition. Kidney international, 2001, Volume: 59, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aldosterone; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Cardiac Output; Cross-Over Studies; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Humans; Kidney Failure, Chronic; Lisinopril; Losartan; Male; Middle Aged; Proteinuria; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renal Circulation; Renin; Urine	2001
Does the antihypertensive response to angiotensin converting enzyme inhibition predict the antihypertensive response to angiotensin receptor antagonism? American journal of hypertension, 2001, Volume: 14, Issue:7 Pt 1 Topics: Adult; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Cross-Over Studies; Female; Humans; Hypertension; Lisinopril; Losartan; Male; Middle Aged; Prospective Studies; Receptor, Angiotensin, Type 1	2001
Add-on angiotensin II receptor blockade lowers urinary transforming growth factor-beta levels. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2002, Volume: 39, Issue:3 Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Cross-Over Studies; Drug Therapy, Combination; Female; Humans; Hypertension; Kidney Failure, Chronic; Lisinopril; Losartan; Male; Middle Aged; Proteinuria; Transforming Growth Factor beta	2002
Dual renin-angiotensin system blockade at optimal doses for proteinuria. Kidney international, 2002, Volume: 62, Issue:3 Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Drug Therapy, Combination; Female; Humans; Lisinopril; Losartan; Male; Middle Aged; Proteinuria; Renin-Angiotensin System	2002
Augmentation of myocardial blood flow in hypertensive heart disease by angiotensin antagonists: a comparison of lisinopril and losartan. Journal of the American College of Cardiology, 2002, Aug-21, Volume: 40, Issue:4 Topics: Adult; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Coronary Circulation; Female; Heart Ventricles; Humans; Hypertension; Hypertrophy, Left Ventricular; Lisinopril; Losartan; Male; Middle Aged; Tomography, Emission-Computed	2002
Assessment of drug effects on blood pressure and pulse pressure using clinic, home and ambulatory measurements. Journal of human hypertension, 2002, Volume: 16, Issue:10 Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Blood Pressure Determination; Blood Pressure Monitoring, Ambulatory; Cross-Over Studies; Female; Home Care Services; Humans; Hypertension; Lisinopril; Losartan; Male; Office Visits; Pulse; Reproducibility of Results; Treatment Outcome	2002
Comparison of the smoothness index, the trough : peak ratio and the morning : evening ratio in assessing the features of the antihypertensive drug effect. Journal of hypertension, 2003, Volume: 21, Issue:5 Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; Cross-Over Studies; Diastole; Drug Evaluation; Female; Humans; Lisinopril; Losartan; Male; Middle Aged; Reproducibility of Results; Systole; Treatment Outcome	2003
Prospective and randomized study of the antihypertensive effect and tolerability of three antihypertensive agents, losartan, amlodipine, and lisinopril, in hypertensive patients. Heart and vessels, 2004, Volume: 19, Issue:1 Topics: Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Cough; Female; Humans; Lisinopril; Losartan; Male; Middle Aged; Prospective Studies	2004
Incidence of hyperkalemia in high risk patients during treatment with an angiotensin converting enzyme inhibitor (Lisinopril) versus an angiotensin II receptor blocker (Losartan). South Dakota journal of medicine, 2004, Volume: 57, Issue:6 Topics: Adult; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cross-Over Studies; Female; Humans; Hyperkalemia; Kidney Failure, Chronic; Lisinopril; Losartan; Male; Middle Aged	2004
Double-blind comparison of losartan, lisinopril and hydrochlorothiazide in hypertensive patients with a previous angiotensin converting enzyme inhibitor-associated cough. Journal of hypertension. Supplement : official journal of the International Society of Hypertension, 1995, Volume: 13, Issue:1 Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Cough; Diuretics; Double-Blind Method; Female; Humans; Hydrochlorothiazide; Hypertension; Incidence; Lisinopril; Losartan; Male; Middle Aged; Pain Measurement	1995
Design of combination angiotensin receptor blocker and angiotensin-converting enzyme inhibitor for treatment of diabetic nephropathy (VA NEPHRON-D). Clinical journal of the American Society of Nephrology : CJASN, 2009, Volume: 4, Issue:2 Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Glomerular Filtration Rate; Humans; Hyperkalemia; Kidney Failure, Chronic; Kidney Transplantation; Lisinopril; Losartan; Prospective Studies; Proteinuria; Renal Dialysis; Research Design; Time Factors; Treatment Outcome; United States; United States Department of Veterans Affairs	2009
Safety and feasibility of achieving lower systolic blood pressure goals in persons with type 2 diabetes: the SANDS trial. Journal of clinical hypertension (Greenwich, Conn.), 2009, Volume: 11, Issue:10 Topics: Aged; Algorithms; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Cardiovascular Diseases; Cholesterol, LDL; Diabetes Mellitus, Type 2; Drug Tolerance; Female; Humans; Hypertension; Lisinopril; Losartan; Male; Middle Aged; United States	2009
Addition of angiotensin receptor blockade or mineralocorticoid antagonism to maximal angiotensin-converting enzyme inhibition in diabetic nephropathy. Journal of the American Society of Nephrology : JASN, 2009, Volume: 20, Issue:12 Topics: Adult; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Bicarbonates; Blood Pressure; Creatinine; Diabetic Nephropathies; Double-Blind Method; Drug Therapy, Combination; Female; Glycated Hemoglobin; Humans; Hypertension; Lisinopril; Losartan; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Potassium; Renin-Angiotensin System; Spironolactone	2009
Comparison of the influence of angiotensin-converting enzyme inhibitor lisinopril and angiotensin II receptor antagonist losartan in patients with idiopathic membranous nephropathy and nephrotic syndrome. Scandinavian journal of urology and nephrology, 2010, Volume: 44, Issue:4 Topics: Adult; Aged; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Female; Glomerular Filtration Rate; Glomerulonephritis, Membranous; Humans; Hypercholesterolemia; Lisinopril; Losartan; Male; Middle Aged; Nephrotic Syndrome; Prevalence; Prospective Studies; Proteinuria	2010
Addition of losartan to angiotensin-converting enzyme inhibitors improves insulin resistance in patients with chronic heart failure treated without β-blockers. Circulation journal : official journal of the Japanese Circulation Society, 2010, Volume: 74, Issue:11 Topics: Adrenergic beta-Antagonists; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Blood Glucose; Chemokine CCL2; Chronic Disease; Cross-Over Studies; Drug Therapy, Combination; Enalapril; Female; Heart Failure; Humans; Imidazolidines; Inflammation Mediators; Insulin; Insulin Resistance; Interleukin-6; Japan; Lisinopril; Losartan; Male; Middle Aged; Time Factors; Treatment Outcome; Tumor Necrosis Factor-alpha	2010
Novel therapies for resistant focal segmental glomerulosclerosis (FONT) phase II clinical trial: study design. BMC nephrology, 2011, Feb-10, Volume: 12 Topics: Adalimumab; Adolescent; Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Anticholesteremic Agents; Atorvastatin; Child; Child, Preschool; Drug Resistance; Drug Therapy, Combination; Follow-Up Studies; Galactose; Glomerulosclerosis, Focal Segmental; Heptanoic Acids; Humans; Infant; Lisinopril; Losartan; Middle Aged; Pyrroles; Treatment Outcome; Young Adult	2011
Placebo effect and efficacy of nebivolol in patients with hypertension not controlled with lisinopril or losartan: a phase IV, randomized, placebo-controlled trial. American journal of cardiovascular drugs : drugs, devices, and other interventions, 2013, Volume: 13, Issue:2 Topics: Adolescent; Adrenergic beta-1 Receptor Antagonists; Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzopyrans; Double-Blind Method; Drug Therapy, Combination; Ethanolamines; Female; Humans; Hypertension; Lisinopril; Losartan; Male; Middle Aged; Nebivolol; Treatment Outcome; United States; Young Adult	2013
Effects of nebivolol on aortic compliance in patients with diabetes and maximal renin angiotensin system blockade: the EFFORT study. Journal of clinical hypertension (Greenwich, Conn.), 2013, Volume: 15, Issue:7 Topics: Adrenergic beta-1 Receptor Antagonists; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Aorta; Benzopyrans; Black or African American; Blood Pressure; Comorbidity; Diabetes Mellitus, Type 2; Ethanolamines; Female; Heart Rate; Hemodynamics; Humans; Hypertension; Lisinopril; Losartan; Male; Metoprolol; Middle Aged; Nebivolol; Renin-Angiotensin System; Treatment Outcome	2013
Combined angiotensin inhibition for the treatment of diabetic nephropathy. The New England journal of medicine, 2013, Nov-14, Volume: 369, Issue:20 Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Diabetic Nephropathies; Double-Blind Method; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Humans; Kaplan-Meier Estimate; Kidney Failure, Chronic; Lisinopril; Losartan; Male; Middle Aged	2013
Potassium handling with dual renin-angiotensin system inhibition in diabetic nephropathy. Clinical journal of the American Society of Nephrology : CJASN, 2014, Volume: 9, Issue:2 Topics: Adult; Aldosterone; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Creatinine; Diabetic Nephropathies; Diuretics; Drug Therapy, Combination; Female; Humans; Hyperkalemia; Lisinopril; Losartan; Male; Middle Aged; Potassium; Prospective Studies; Renin-Angiotensin System; Risk Factors; Sodium; Spironolactone; Texas; Time Factors; Treatment Outcome	2014
Randomized controlled trial of mycophenolate mofetil in children, adolescents, and adults with IgA nephropathy. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2015, Volume: 66, Issue:5 Topics: Adolescent; Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Child; Creatinine; Dietary Supplements; Docosahexaenoic Acids; Double-Blind Method; Drug Combinations; Drug Therapy, Combination; Eicosapentaenoic Acid; Female; Glomerular Filtration Rate; Glomerulonephritis, IGA; Humans; Immunosuppressive Agents; Lisinopril; Losartan; Male; Middle Aged; Mycophenolic Acid; Proteinuria; Remission Induction; Treatment Outcome; Young Adult	2015
BP and Renal Outcomes in Diabetic Kidney Disease: The Veterans Affairs Nephropathy in Diabetes Trial. Clinical journal of the American Society of Nephrology : CJASN, 2015, Dec-07, Volume: 10, Issue:12 Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Diabetic Nephropathies; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Humans; Hypertension; Kidney Failure, Chronic; Lisinopril; Losartan; Male; Middle Aged; Multivariate Analysis; Proportional Hazards Models; Proteinuria; Risk Factors; Time Factors; Treatment Outcome; United States; United States Department of Veterans Affairs	2015
Lisinopril versus lisinopril and losartan for mild childhood IgA nephropathy: a randomized controlled trial (JSKDC01 study). Pediatric nephrology (Berlin, Germany), 2019, Volume: 34, Issue:5 Topics: Adolescent; Child; Child, Preschool; Drug Therapy, Combination; Female; Glomerulonephritis, IGA; Humans; Kidney Glomerulus; Lisinopril; Losartan; Male; Prospective Studies; Proteinuria; Severity of Illness Index; Treatment Outcome	2019

Other Studies

96 other study(ies) available for losartan and lisinopril

Article	Year
Interaction of digoxin with antihypertensive drugs via MDR1. Life sciences, 2002, Feb-15, Volume: 70, Issue:13 Topics: Animals; Antihypertensive Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cells, Cultured; Digoxin; Drug Interactions; Humans; Time Factors	2002
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Physicochemical determinants of human renal clearance. Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15 Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight	2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination. Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3 Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations	2010
How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability? Journal of medicinal chemistry, 2010, May-13, Volume: 53, Issue:9 Topics: Animals; Disease Models, Animal; Dogs; Humans; Jejunal Diseases; Kidney Diseases; Models, Biological; Permeability; Porosity; Regression Analysis	2010
Developing structure-activity relationships for the prediction of hepatotoxicity. Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes	2010
A predictive ligand-based Bayesian model for human drug-induced liver injury. Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12 Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands	2010
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology. Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3 Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries	2023
Angiotensin-(1-7) and nitric oxide interaction in renovascular hypertension. Hypertension (Dallas, Tex. : 1979), 1995, Volume: 25, Issue:4 Pt 2 Topics: Amino Acid Oxidoreductases; Angiotensin I; Angiotensin II; Angiotensins; Animals; Arginine; Biphenyl Compounds; Dogs; Hemodynamics; Hypertension, Renovascular; Imidazoles; Lisinopril; Losartan; Male; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; Peptide Fragments; Peptidyl-Dipeptidase A; Tetrazoles	1995
Tissue- and subtype-specific modulation of angiotensin II receptors by chronic treatment with cyclosporin A, angiotensin-converting enzyme inhibitors and AT1 antagonists. Journal of cardiovascular pharmacology, 1995, Volume: 26, Issue:1 Topics: Administration, Oral; Adrenal Cortex; Adrenal Medulla; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Biphenyl Compounds; Cyclosporine; Down-Regulation; Drug Interactions; Imidazoles; Kidney; Lisinopril; Liver; Losartan; Male; Pyridines; Quinolines; Radioligand Assay; Rats; Rats, Wistar; Receptors, Angiotensin; Tetrazoles; Up-Regulation	1995
Control of carotid vasomotor tone by local renin-angiotensin system in normotensive and spontaneously hypertensive rats. Role of endothelium and flow. Circulation research, 1995, Volume: 77, Issue:2 Topics: Analysis of Variance; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Biphenyl Compounds; Carotid Arteries; Endothelium, Vascular; Hypertension; Imidazoles; In Vitro Techniques; Lisinopril; Losartan; Perfusion; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Renin-Angiotensin System; Tetrazoles; Transducers; Vasomotor System	1995
Sympathetic nerve activity in conscious renal hypertensive rats treated with an angiotensin converting enzyme inhibitor or an angiotensin II antagonist. Journal of hypertension, 1995, Volume: 13, Issue:4 Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Blood Pressure; Disease Models, Animal; Heart Rate; Hypertension, Renal; Imidazoles; Lisinopril; Losartan; Male; Nitroprusside; Rats; Rats, Wistar; Renin-Angiotensin System; Splanchnic Nerves; Sympathetic Nervous System; Tetrazoles	1995
Effects of blocking the angiotensin II receptor, converting enzyme, and renin activity on the renal hemodynamics of normotensive guinea pigs. Journal of cardiovascular pharmacology, 1993, Volume: 22, Issue:2 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Blood Pressure; Body Weight; Diuresis; Glomerular Filtration Rate; Guinea Pigs; Imidazoles; Kidney Function Tests; Lisinopril; Losartan; Male; Renal Circulation; Renin; Tetrazoles	1993
Prevention of angiotensin II induced myocyte necrosis and coronary vascular damage by lisinopril and losartan in the rat. Cardiovascular research, 1995, Volume: 29, Issue:4 Topics: Angiotensin I; Angiotensin II; Animals; Biphenyl Compounds; Coronary Vessels; Dose-Response Relationship, Drug; Heart; Hypertension, Renovascular; Imidazoles; Lisinopril; Losartan; Male; Necrosis; Rats; Rats, Sprague-Dawley; Tetrazoles	1995
Angiotensin II receptor binding following myocardial infarction in the rat. Cardiovascular research, 1994, Volume: 28, Issue:11 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Autoradiography; Biphenyl Compounds; Collagen; Fibrosis; Foreign-Body Reaction; Imidazoles; Lisinopril; Losartan; Male; Myocardial Infarction; Myocardium; Peptidyl-Dipeptidase A; Protein Binding; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Tetrazoles	1994
Regulation of the renal angiotensin II receptor gene in acute unilateral ureteral obstruction. Kidney international, 1994, Volume: 45, Issue:6 Topics: Acute Disease; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Down-Regulation; Gene Expression Regulation; Imidazoles; Kidney; Lisinopril; Losartan; Male; Rats; Rats, Wistar; Receptors, Angiotensin; RNA, Messenger; Tetrazoles; Ureteral Obstruction	1994
Mechanisms of hypertension in transgenic rats expressing the mouse Ren-2 gene. The American journal of physiology, 1994, Volume: 266, Issue:4 Pt 2 Topics: Angiotensin II; Animals; Animals, Genetically Modified; Antihypertensive Agents; Arginine; Biphenyl Compounds; Blood Pressure; Endothelins; Female; Gene Expression; Hemodynamics; Hypertension; Imidazoles; Lisinopril; Losartan; Mice; omega-N-Methylarginine; Rats; Rats, Sprague-Dawley; Reference Values; Tetrazoles	1994
Role of nitric oxide and angiotensin II in the regulation of sympathetic nerve activity in spontaneously hypertensive rats. Hypertension (Dallas, Tex. : 1979), 1993, Volume: 21, Issue:4 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Biphenyl Compounds; Blood Pressure; Dipeptides; Heart Rate; Imidazoles; Lisinopril; Losartan; Male; Nitric Oxide; Oligopeptides; omega-N-Methylarginine; Pressoreceptors; Rats; Rats, Inbred SHR; Reflex; Tetrazoles	1993
Regulation of renin-angiotensin system in unilateral ureteral obstruction. Kidney international, 1993, Volume: 44, Issue:2 Topics: Animals; Biphenyl Compounds; Blotting, Northern; Dipeptides; Diuresis; Eicosanoids; Electrolytes; Hemodynamics; Imidazoles; Immunohistochemistry; In Situ Hybridization; Kidney; Lisinopril; Losartan; Male; Rats; Rats, Inbred Strains; Renin; Renin-Angiotensin System; RNA, Messenger; Tetrazoles; Ureteral Obstruction	1993
Angioedema of the intestine. The New England journal of medicine, 1996, 11-14, Volume: 335, Issue:20 Topics: Angioedema; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biphenyl Compounds; Humans; Imidazoles; Intestinal Diseases; Lisinopril; Losartan; Tetrazoles	1996
Fibrous tissue and angiotensin II. Journal of molecular and cellular cardiology, 1997, Volume: 29, Issue:8 Topics: Actins; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Collagen; Connective Tissue; Croton Oil; Fibroblasts; Granuloma; Hydroxyproline; Imidazoles; Lisinopril; Losartan; Macrophages; Male; Peptidyl-Dipeptidase A; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Wound Healing	1997
Actions of angiotensin and lisinopril on thalamic somatosensory neurons in normotensive, non-transgenic and hypertensive, transgenic rats. Journal of hypertension, 1997, Volume: 15, Issue:10 Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Genetically Modified; Antihypertensive Agents; Disease Models, Animal; Electroencephalography; Hypertension; Imidazoles; Lisinopril; Losartan; Male; Neurons, Afferent; Pyridines; Rats; Rats, Sprague-Dawley; Rats, Wistar; Thalamus; Vasoconstrictor Agents	1997
Angiotensin-(1-7) contributes to the antihypertensive effects of blockade of the renin-angiotensin system. Hypertension (Dallas, Tex. : 1979), 1998, Volume: 31, Issue:1 Pt 2 Topics: Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Bradykinin; Dipeptides; Heart Rate; Hypertension; Kinetics; Lisinopril; Losartan; Male; Neprilysin; Organophosphonates; Peptide Fragments; Peptides, Cyclic; Phenylalanine; Protease Inhibitors; Rats; Rats, Inbred SHR; Renin-Angiotensin System	1998
Vasodepressor actions of angiotensin-(1-7) unmasked during combined treatment with lisinopril and losartan. Hypertension (Dallas, Tex. : 1979), 1998, Volume: 31, Issue:2 Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antibodies, Monoclonal; Antihypertensive Agents; Blood Pressure; Heart Rate; Imidazoles; Immunoglobulin G; Lisinopril; Losartan; Male; Mice; Mice, Inbred BALB C; Peptide Fragments; Pyridines; Rats; Rats, Inbred SHR; Vasodilation	1998
Pouch tissue and angiotensin peptide generation. Journal of molecular and cellular cardiology, 1998, Volume: 30, Issue:7 Topics: Angiotensin I; Angiotensin II; Angiotensinogen; Angiotensins; Animals; Aspartic Acid Endopeptidases; Cathepsin D; Collagen; Gene Expression; Imidazoles; Lisinopril; Losartan; Myocardium; Peptide Biosynthesis; Peptides; Peptidyl-Dipeptidase A; Pyridines; Rats; Renin; Transforming Growth Factor beta	1998
Converting enzyme determines plasma clearance of angiotensin-(1-7). Hypertension (Dallas, Tex. : 1979), 1998, Volume: 32, Issue:3 Topics: Administration, Oral; Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Genetically Modified; Blood Pressure; Chromatography, High Pressure Liquid; Drug Combinations; Half-Life; Lisinopril; Losartan; Male; Metabolic Clearance Rate; Peptide Fragments; Radioimmunoassay; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Species Specificity	1998
Aphtous ulcers of the mouth associated with losartan. Clinical nephrology, 1998, Volume: 50, Issue:3 Topics: Antihypertensive Agents; Dysgeusia; Female; Humans; Hypertension; Kidney Failure, Chronic; Lisinopril; Losartan; Middle Aged; Polycystic Kidney, Autosomal Dominant; Stomatitis, Aphthous	1998
Cough and angiotensin II receptor antagonists: cause or confounding? British journal of clinical pharmacology, 1999, Volume: 47, Issue:1 Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Cohort Studies; Confounding Factors, Epidemiologic; Cough; Data Collection; Drug Monitoring; Enalapril; Female; Humans; Indoles; Lisinopril; Losartan; Male; Middle Aged; Perindopril	1999
Differential response of angiotensin peptides in the urine of hypertensive animals. Regulatory peptides, 1999, Mar-17, Volume: 80, Issue:1-2 Topics: Administration, Oral; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Genetically Modified; Antihypertensive Agents; Blood Pressure; Body Weight; Drinking; Electrolytes; Hemodynamics; Hypertension; Lisinopril; Losartan; Male; Peptide Fragments; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley	1999
Losartan-induced cough after lisinopril therapy. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1999, May-01, Volume: 56, Issue:9 Topics: Aged; Angiotensin II; Antihypertensive Agents; Cough; Female; Humans; Lisinopril; Losartan; Randomized Controlled Trials as Topic	1999
Endothelin, but not angiotensin II, contributes to the hypoxic contractile response of large isolated pulmonary arteries in the rat. Fundamental & clinical pharmacology, 1999, Volume: 13, Issue:4 Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Azepines; Bosentan; Calcium; Calcium Channel Blockers; Endothelin Receptor Antagonists; Endothelins; Endothelium, Vascular; Extracellular Space; Glycopeptides; Hypoxia; In Vitro Techniques; Indoles; Lisinopril; Losartan; Male; Muscle Contraction; Muscle, Smooth, Vascular; Nicardipine; Pulmonary Artery; Rats; Rats, Wistar; Sulfonamides	1999
No acute additive effect of losartan in a patient already on an ACE inhibitor for heart failure. Journal of human hypertension, 1999, Volume: 13, Issue:11 Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cardiac Output, Low; Drug Synergism; Drug Therapy, Combination; Humans; Lisinopril; Losartan; Male; Middle Aged; Time Factors	1999
Angiotensin II-induced superoxide anion generation in human vascular endothelial cells: role of membrane-bound NADH-/NADPH-oxidases. Cardiovascular research, 1999, Volume: 44, Issue:1 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cells, Cultured; Dose-Response Relationship, Drug; Endothelium, Vascular; Humans; Imidazoles; Lisinopril; Losartan; NADH Dehydrogenase; NADPH Oxidases; Pyridines; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Reverse Transcriptase Polymerase Chain Reaction; Stimulation, Chemical; Superoxides	1999
[Angioedema-urticaria caused by angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists]. Medicina clinica, 1999, Dec-04, Volume: 113, Issue:19 Topics: Aged; Aged, 80 and over; Angioedema; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Humans; Lisinopril; Losartan; Male	1999
Role of patient factors in therapy resistance to antiproteinuric intervention in nondiabetic and diabetic nephropathy. Kidney international. Supplement, 2000, Volume: 75 Topics: Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Diabetic Nephropathies; Enalapril; Humans; Indomethacin; Kidney Diseases; Lisinopril; Losartan; Proteinuria	2000
Losartan-induced cough after lisinopril therapy. American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2000, May-15, Volume: 57, Issue:10 Topics: Aged; Aged, 80 and over; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cough; Female; Humans; Lisinopril; Losartan	2000
Evidence that prostaglandins mediate the antihypertensive actions of angiotensin-(1-7) during chronic blockade of the renin-angiotensin system. Journal of cardiovascular pharmacology, 2000, Volume: 36, Issue:1 Topics: Angiotensin I; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Blood Pressure; Cyclooxygenase Inhibitors; Heart Rate; Lisinopril; Losartan; Male; Peptide Fragments; Prostaglandins; Rats; Rats, Inbred SHR; Receptors, Angiotensin; Renin-Angiotensin System	2000
Angiogenesis induced by electrical stimulation is mediated by angiotensin II and VEGF. Microcirculation (New York, N.Y. : 1994), 2001, Volume: 8, Issue:1 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Electric Stimulation; Endothelial Growth Factors; Lisinopril; Losartan; Lymphokines; Male; Muscle, Skeletal; Neovascularization, Physiologic; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors	2001
Suppression of experimental abdominal aortic aneurysms in the rat by treatment with angiotensin-converting enzyme inhibitors. Journal of vascular surgery, 2001, Volume: 33, Issue:5 Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Blood Pressure; Captopril; Enalapril; Lisinopril; Losartan; Male; Pancreatic Elastase; Rats; Rats, Wistar	2001
Endothelial factors and microvascular hypertensive disease. Journal of cardiovascular pharmacology, 2001, Volume: 38 Suppl 2 Topics: Acetylcholine; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Calcium Channel Blockers; Cilazapril; Dose-Response Relationship, Drug; Endothelium, Vascular; Humans; Hypertension; Lisinopril; Losartan; Nifedipine; Nitric Oxide; Rats; Rats, Inbred SHR; Vascular Resistance; Vasoconstriction; Vasodilator Agents	2001
Non-AT(1)-receptor-mediated protective effect of angiotensin against acute ischaemic stroke in the gerbil. Journal of the renin-angiotensin-aldosterone system : JRAAS, 2001, Volume: 2, Issue:2 Topics: Acute Disease; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Brain Ischemia; Disease Models, Animal; Enalapril; Gerbillinae; Lisinopril; Losartan; Male; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Reproducibility of Results; Stroke; Tetrazoles	2001
[Treatment of post kidney transplantation erythrocytosis (PTE) with ACE inhibitors]. Minerva urologica e nefrologica = The Italian journal of urology and nephrology, 2002, Volume: 54, Issue:2 Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cyclosporine; Drug Evaluation; Female; Follow-Up Studies; Hematocrit; Humans; Immunosuppressive Agents; Kidney Transplantation; Lisinopril; Losartan; Male; Polycythemia; Postoperative Complications; Retrospective Studies	2002
ACE and non-ACE mediated effect of angiotensin I on intracellular calcium mobilization in rat glomerular arterioles. American journal of physiology. Heart and circulatory physiology, 2003, Volume: 284, Issue:6 Topics: Algorithms; Angiotensin I; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Arterioles; Calcium; Cysteine Proteinase Inhibitors; Dose-Response Relationship, Drug; In Vitro Techniques; Juxtaglomerular Apparatus; Kidney Glomerulus; Lisinopril; Losartan; Muscle, Smooth; Peptidyl-Dipeptidase A; Rats; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Renal Circulation; Serine Proteinase Inhibitors; Spectrometry, Fluorescence	2003
ANG II is involved in the LPS-induced production of proinflammatory cytokines in dehydrated rats. American journal of physiology. Regulatory, integrative and comparative physiology, 2003, Volume: 284, Issue:4 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Dehydration; Gene Expression Regulation; Interleukin-1; Interleukin-6; Lipopolysaccharides; Lisinopril; Liver; Losartan; Male; Rats; Rats, Wistar; RNA, Messenger; Time Factors	2003
Myogenic constriction is increased in mesenteric resistance arteries from rats with chronic heart failure: instantaneous counteraction by acute AT1 receptor blockade. British journal of pharmacology, 2003, Volume: 139, Issue:7 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Bridged Bicyclo Compounds, Heterocyclic; Captopril; Chronic Disease; Coronary Vessels; Disease Models, Animal; Endothelium-Dependent Relaxing Factors; Endothelium, Vascular; Fatty Acids, Unsaturated; Heart; Heart Failure; Hydrazines; Imidazoles; Indomethacin; Lisinopril; Losartan; Male; Mesenteric Arteries; Nitric Oxide; omega-N-Methylarginine; Pyridines; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Superoxide Dismutase; Sympathetic Nervous System; Tetrazoles; Tetrodotoxin; Vascular Resistance	2003
The effect of central injection of angiotensin-converting enzyme inhibitor and the angiotensin type 1 receptor antagonist on the induction by lipopolysaccharide of fever and brain interleukin-1beta response in rats. The Journal of pharmacology and experimental therapeutics, 2004, Volume: 308, Issue:3 Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Animals; Antihypertensive Agents; Brain; Disease Models, Animal; Fever; Injections; Interleukin-1; Lipopolysaccharides; Lisinopril; Losartan; Male; Rats; Rats, Wistar	2004
Efficacy of losartan in the treatment of erythrocytosis in a young adult with CRF. Pediatric nephrology (Berlin, Germany), 2004, Volume: 19, Issue:1 Topics: Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Drug Therapy, Combination; Humans; Kidney Failure, Chronic; Lisinopril; Losartan; Male; Polycythemia; Treatment Outcome	2004
The renin-angiotensin system and the developing retinal vasculature. Investigative ophthalmology & visual science, 2005, Volume: 46, Issue:3 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Animals, Genetically Modified; Autoradiography; Immunoenzyme Techniques; Lisinopril; Losartan; Neovascularization, Physiologic; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin; Renin-Angiotensin System; Retinal Ganglion Cells; Retinal Vessels	2005
[Myocardial remodeling after experimental acute myocardial infarction in rats. Effect of renin-angiotensin-aldosterone blockade]. Arquivos brasileiros de cardiologia, 2005, Volume: 84, Issue:1 Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Disease Models, Animal; Hypertrophy, Left Ventricular; Lisinopril; Losartan; Male; Myocardial Infarction; Rats; Rats, Wistar; Ventricular Remodeling	2005
[Blockade of renin-angiotensin system attenuates cardiac remodeling in rats undergoing aortic stenosis]. Arquivos brasileiros de cardiologia, 2005, Volume: 84, Issue:4 Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Aortic Valve Stenosis; Echocardiography; Hydroxyproline; Hypertrophy, Left Ventricular; Lisinopril; Losartan; Male; Rats; Rats, Wistar; Ventricular Remodeling	2005
Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. Circulation, 2005, May-24, Volume: 111, Issue:20 Topics: Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Carboxypeptidases; Gene Expression Regulation; Lisinopril; Losartan; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Rats, Inbred Lew; RNA, Messenger	2005
Cellular cholesterol efflux to plasma from proteinuric patients is elevated and remains unaffected by antiproteinuric treatment. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2006, Volume: 21, Issue:1 Topics: Adult; Analysis of Variance; Apolipoproteins; Biological Transport; Case-Control Studies; Cholesterol, HDL; Humans; Hyperlipidemias; Kidney Failure, Chronic; Kidney Function Tests; Lisinopril; Losartan; Male; Middle Aged; Phospholipid Transfer Proteins; Probability; Prognosis; Proteinuria; Reference Values; Risk Factors; Sensitivity and Specificity; Severity of Illness Index	2006
Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptors. Kidney international, 2005, Volume: 68, Issue:5 Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Carboxypeptidases; Gene Expression Regulation, Enzymologic; Hypertension, Renal; Kidney; Lisinopril; Losartan; Male; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Rats, Inbred Lew; Receptors, Angiotensin; Renin-Angiotensin System	2005
[A new approach to treating secondary pulmonary hypertension]. Problemy tuberkuleza i boleznei legkikh, 2005, Issue:9 Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Bronchitis, Chronic; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Hypertension, Pulmonary; Lisinopril; Losartan; Male; Middle Aged	2005
Effects of central injection of angiotensin-converting-enzyme inhibitor and angiotensin type 1 receptor antagonist on the brain NF-kappaB and AP-1 activities of rats given LPS. Peptides, 2006, Volume: 27, Issue:6 Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Brain; Cytokines; Lipopolysaccharides; Lisinopril; Losartan; Male; NF-kappa B; Rats; Rats, Wistar; Transcription Factor AP-1	2006
Effect of angiotensin II blockade on a new congenic model of hypertension derived from transgenic Ren-2 rats. American journal of physiology. Heart and circulatory physiology, 2006, Volume: 291, Issue:5 Topics: Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Congenic; Animals, Genetically Modified; Crosses, Genetic; Hypertension, Renal; Kinetics; Lisinopril; Losartan; Male; Models, Genetic; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Rats, Inbred Lew; Renin; Renin-Angiotensin System; RNA, Messenger; Time Factors	2006
Acute renal failure during lisinopril and losartan therapy for proteinuria. Pharmacotherapy, 2006, Volume: 26, Issue:9 Topics: Acute Kidney Injury; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Child; Drug Therapy, Combination; Humans; Hypotension; Lisinopril; Losartan; Male; Proteinuria	2006
Angiotensin-converting enzyme inhibitor enhances liver regeneration following partial hepatectomy: involvement of bradykinin B2 and angiotensin AT1 receptors. Biological & pharmaceutical bulletin, 2007, Volume: 30, Issue:3 Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Bradykinin; Bradykinin B2 Receptor Antagonists; Bromodeoxyuridine; Dose-Response Relationship, Drug; Hepatectomy; Hepatocyte Growth Factor; Hepatocytes; Lisinopril; Liver Regeneration; Losartan; Male; Rats; Rats, Sprague-Dawley; Receptor, Bradykinin B2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetrazoles; Time Factors	2007
CX3CR1 receptor is up-regulated in monocytes of coronary artery diseased patients: impact of pre-inflammatory stimuli and renin-angiotensin system modulators. Thrombosis research, 2007, Volume: 121, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Captopril; Case-Control Studies; Cell Line; Coronary Artery Disease; CX3C Chemokine Receptor 1; Female; Humans; In Vitro Techniques; Inflammation Mediators; Interferon-gamma; Jurkat Cells; Lisinopril; Losartan; Male; Middle Aged; Monocytes; Receptors, Chemokine; Recombinant Proteins; Renin-Angiotensin System; Tumor Necrosis Factor-alpha; Up-Regulation	2007
Inhibition of the renin-angiotensin system attenuates the development of liver fibrosis and oxidative stress in rats. Clinical and experimental pharmacology & physiology, 2008, Volume: 35, Issue:2 Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; Carbon Tetrachloride; Disease Models, Animal; Dose-Response Relationship, Drug; Fosinopril; Glutathione; Hydroxyproline; Lipid Peroxidation; Lisinopril; Liver; Liver Cirrhosis; Liver Function Tests; Losartan; Male; Oxidative Stress; Rats; Renin-Angiotensin System	2008
Antidepressant activity of fosinopril, ramipril and losartan, but not of lisinopril in depressive paradigms of albino rats and mice. Indian journal of experimental biology, 2008, Volume: 46, Issue:3 Topics: Amitriptyline; Analysis of Variance; Animals; Antidepressive Agents; Antihypertensive Agents; Fosinopril; Lisinopril; Long-Term Synaptic Depression; Losartan; Male; Mice; Motor Activity; Ramipril; Rats; Rats, Wistar	2008
RAS inhibitors decrease apoptosis of acinar cells and increase elimination of pancreatic stellate cells after in the course of experimental chronic pancreatitis induced by dibutyltin dichloride. Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2008, Volume: 59 Suppl 2 Topics: Actins; Aldosterone; Animals; Apoptosis; Captopril; Cell Proliferation; Enalapril; Immunohistochemistry; Lisinopril; Losartan; Male; Organotin Compounds; Pancreas; Pancreatitis, Chronic; Rats; Rats, Inbred Lew; Renin-Angiotensin System	2008
[Clinical state of a patient with nephrotic proteinuria successfully treated with combined therapy with angiotensin II receptor antagonists and angiotensin II converting enzyme inhibitors and pentoxifylline]. Przeglad lekarski, 2008, Volume: 65, Issue:6 Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Hepatitis C; Humans; Hypertension; Kidney Diseases; Lisinopril; Losartan; Male; Middle Aged; Pentoxifylline; Proteinuria	2008
Dual ACE-inhibition and AT1 receptor antagonism improves ventricular lusitropy without affecting cardiac fibrosis in the congenic mRen2.Lewis rat. Therapeutic advances in cardiovascular disease, 2009, Volume: 3, Issue:4 Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Congenic; Blood Pressure; Calcium-Binding Proteins; Collagen; Disease Models, Animal; Drug Administration Schedule; Drug Therapy, Combination; Echocardiography, Doppler; Fibrosis; Heart Rate; Hypertension; Hypertrophy, Left Ventricular; Lisinopril; Losartan; Male; Myocardial Contraction; Myocardium; Rats; Rats, Inbred Lew; Rats, Transgenic; Renin; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Ventricular Function, Left	2009
[Effect of renin-angiotensin system inhibitors on the density of myocardial, pericardial and pulmonary rat mast cells under experimental heart failure]. Tsitologiia, 2009, Volume: 51, Issue:9 Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Cell Count; Disease Models, Animal; Heart Failure; Lisinopril; Losartan; Lung; Male; Mast Cells; Myocardium; Pericardium; Rats; Rats, Wistar	2009
Antihypertensive activity of Salvia elegans Vahl. (Lamiaceae): ACE inhibition and angiotensin II antagonism. Journal of ethnopharmacology, 2010, Jul-20, Volume: 130, Issue:2 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Chromatography, Thin Layer; Disease Models, Animal; Dose-Response Relationship, Drug; Hypertension; Injections, Intravenous; Kinetics; Lisinopril; Losartan; Mice; Mice, Inbred ICR; Peptidyl-Dipeptidase A; Plant Components, Aerial; Plant Extracts; Salvia; Spectrophotometry, Ultraviolet	2010
CYP4A2-induced hypertension is 20-hydroxyeicosatetraenoic acid- and angiotensin II-dependent. Hypertension (Dallas, Tex. : 1979), 2010, Volume: 56, Issue:5 Topics: Amidines; Analysis of Variance; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Blotting, Western; Cells, Cultured; Cytochrome P-450 Enzyme System; Endothelium, Vascular; Hydroxyeicosatetraenoic Acids; Hypertension; Lentivirus; Lisinopril; Losartan; Mass Spectrometry; Oligonucleotide Array Sequence Analysis; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Reverse Transcriptase Polymerase Chain Reaction; Time Factors	2010
The effect of anti-hypertensive drugs on the obstructive pancreatitis in rats. Acta cirurgica brasileira, 2010, Volume: 25, Issue:5 Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Collagen; Disease Models, Animal; Lisinopril; Losartan; Male; Pancreatic Stellate Cells; Pancreatitis; Random Allocation; Rats; Rats, Wistar	2010
[Effect of losartan, lisinopril and their combination on hemodynamics and morphofunctional parameters of the heart in patients with chronic cardiac failure]. Klinicheskaia meditsina, 2011, Volume: 89, Issue:1 Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Cardiotonic Agents; Drug Therapy, Combination; Echocardiography; Exercise Test; Female; Follow-Up Studies; Heart Failure; Hemodynamics; Humans; Lisinopril; Losartan; Male; Middle Aged; Treatment Outcome; Ventricular Function	2011
Directly acting drugs prostacyclin or nitroglycerine and endothelin receptor blocker bosentan improve cell engraftment in rodent liver. Hepatology (Baltimore, Md.), 2013, Volume: 57, Issue:1 Topics: Animals; Bosentan; Cardiovascular Agents; Dipeptidyl Peptidase 4; Endothelin Receptor Antagonists; Epoprostenol; Hepatocytes; Lisinopril; Liver; Losartan; Nitroglycerin; Rats; Rats, Inbred F344; Sulfonamides	2013
Comparison between the effects of lisinopril and losartan on the cougn reflex in anesthetized and awake rabbits. Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2013, Volume: 64, Issue:2 Topics: Administration, Inhalation; Administration, Intravenous; Anesthesia; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Citric Acid; Cough; Lisinopril; Losartan; Male; Physical Stimulation; Rabbits; Reflex	2013
The end of dual therapy with renin-angiotensin-aldosterone system blockade? The New England journal of medicine, 2013, Nov-14, Volume: 369, Issue:20 Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Diabetic Nephropathies; Female; Humans; Lisinopril; Losartan; Male	2013
Serum potassium in dual renin-angiotensin-aldosterone system blockade. Clinical journal of the American Society of Nephrology : CJASN, 2014, Volume: 9, Issue:2 Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Diabetic Nephropathies; Diuretics; Female; Humans; Lisinopril; Losartan; Male; Potassium; Renin-Angiotensin System; Spironolactone	2014
Prednisolone attenuates improvement of cardiac and skeletal contractile function and histopathology by lisinopril and spironolactone in the mdx mouse model of Duchenne muscular dystrophy. PloS one, 2014, Volume: 9, Issue:2 Topics: Animals; Cardiotonic Agents; Disease Models, Animal; Diuretics; Dystrophin; Female; Gene Expression; Glucocorticoids; Humans; Lisinopril; Losartan; Male; Mice; Mice, Inbred mdx; Muscle Contraction; Muscle Weakness; Muscle, Skeletal; Muscular Dystrophy, Animal; Muscular Dystrophy, Duchenne; Myocardium; Prednisolone; Spironolactone; Utrophin	2014
Combined angiotensin inhibition in diabetic nephropathy. The New England journal of medicine, 2014, 02-20, Volume: 370, Issue:8 Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Diabetic Nephropathies; Female; Humans; Lisinopril; Losartan; Male	2014
Combined angiotensin inhibition in diabetic nephropathy. The New England journal of medicine, 2014, 02-20, Volume: 370, Issue:8 Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Diabetic Nephropathies; Female; Humans; Lisinopril; Losartan; Male	2014
Combined angiotensin inhibition in diabetic nephropathy. The New England journal of medicine, 2014, 02-20, Volume: 370, Issue:8 Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Diabetic Nephropathies; Female; Humans; Lisinopril; Losartan; Male	2014
Combined angiotensin inhibition in diabetic nephropathy. The New England journal of medicine, 2014, 02-20, Volume: 370, Issue:8 Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Diabetic Nephropathies; Female; Humans; Lisinopril; Losartan; Male	2014
Combined angiotensin inhibition in diabetic nephropathy. The New England journal of medicine, 2014, 02-20, Volume: 370, Issue:8 Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Diabetic Nephropathies; Female; Humans; Lisinopril; Losartan; Male	2014
[Dual blockade of the renin-angiotensin system in diabetic patients is dangerous]. Praxis, 2014, Feb-26, Volume: 103, Issue:5 Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Diabetic Nephropathies; Female; Humans; Lisinopril; Losartan; Male	2014
Angiotensinergic neurotransmission in the paraventricular nucleus of the hypothalamus modulates the pressor response to acute restraint stress in rats. Neuroscience, 2014, Jun-13, Volume: 270 Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Blood-Brain Barrier; Cardiovascular Physiological Phenomena; Heart Rate; Lisinopril; Losartan; Male; Paraventricular Hypothalamic Nucleus; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Restraint, Physical; Stress, Psychological; Synaptic Transmission; Tachycardia	2014
Dual therapy difficulties in angiotensin blockade for proteinuria: a teachable moment. JAMA internal medicine, 2014, Volume: 174, Issue:9 Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Creatinine; Drug Therapy, Combination; Humans; Lisinopril; Losartan; Proteinuria	2014
Severe Angioedema Associated With Angiotensin-Converting Enzyme Inhibitor Therapy in Two Patients With Pollen-Food Allergy Syndrome. Journal of clinical hypertension (Greenwich, Conn.), 2015, Volume: 17, Issue:6 Topics: Aged; Angioedema; Angiotensin-Converting Enzyme Inhibitors; Humans; Lisinopril; Losartan; Male; Middle Aged; Rhinitis, Allergic, Seasonal; Treatment Outcome	2015
Angiotensin receptor blocker-induced visceral angioedema. Journal of investigational allergology & clinical immunology, 2015, Volume: 25, Issue:1 Topics: Abdominal Pain; Adult; Angioedema; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Diagnosis, Differential; Female; Humans; Lisinopril; Losartan	2015
The renin-angiotensin system and its vasoactive metabolite angiotensin-(1-7) in the mechanism of the healing of preexisting gastric ulcers. The involvement of Mas receptors, nitric oxide, prostaglandins and proinflammatory cytokines. Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2016, Volume: 67, Issue:1 Topics: Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cytokines; Enzyme Inhibitors; Gastric Mucosa; Imidazoles; Indomethacin; Interleukin-1beta; Lisinopril; Losartan; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Peptide Fragments; Prostaglandins; Proto-Oncogene Mas; Proto-Oncogene Proteins; Rats; Rats, Wistar; Receptors, G-Protein-Coupled; Renin-Angiotensin System; Stomach Ulcer; Superoxide Dismutase; Tumor Necrosis Factor-alpha	2016
Incidence, Severity, and Outcomes of AKI Associated with Dual Renin-Angiotensin System Blockade. Clinical journal of the American Society of Nephrology : CJASN, 2016, 11-07, Volume: 11, Issue:11 Topics: Acute Kidney Injury; Aged; Albuminuria; Blood Pressure; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Heart Failure; Humans; Incidence; Kidney Failure, Chronic; Lisinopril; Losartan; Male; Middle Aged; Recovery of Function; Renin-Angiotensin System; Risk Factors	2016
The comparative efficacy of renin-angiotensin system blockers in schistosomal hepatic fibrosis. Experimental parasitology, 2018, Volume: 191 Topics: Amides; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Bradykinin; Fumarates; Lisinopril; Liver; Liver Cirrhosis; Losartan; Male; Mice; Mice, Inbred BALB C; Nitric Oxide Synthase Type III; p38 Mitogen-Activated Protein Kinases; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Renin; Renin-Angiotensin System; Schistosomiasis mansoni; Tissue Inhibitor of Metalloproteinase-1; Transforming Growth Factor beta1; Vasodilator Agents	2018
IgA nephropathy: is a new approach beyond proteinuria necessary? Pediatric nephrology (Berlin, Germany), 2019, Volume: 34, Issue:5 Topics: Child; Glomerulonephritis, IGA; Humans; Lisinopril; Losartan; Proteinuria	2019
Effects of Different Antihypertensive Drug Combinations on Blood Pressure and Arterial Stiffness. Medical archives (Sarajevo, Bosnia and Herzegovina), 2019, Volume: 73, Issue:3 Topics: Aged; Amlodipine; Antihypertensive Agents; Arteries; Blood Pressure; Diastole; Drug Combinations; Essential Hypertension; Female; Humans; Hydrochlorothiazide; Lisinopril; Losartan; Male; Middle Aged; Prospective Studies; Pulse Wave Analysis; Systole; Valsartan; Vascular Resistance; Vascular Stiffness	2019
Oral Manifestations of Commonly Prescribed Drugs. American family physician, 2020, 11-15, Volume: 102, Issue:10 Topics: Albuterol; Amlodipine; Anticonvulsants; Antihypertensive Agents; Atorvastatin; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bronchodilator Agents; Deprescriptions; Drug Hypersensitivity; Fluorides; Gingival Overgrowth; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperpigmentation; Hypoglycemic Agents; Lisinopril; Losartan; Metformin; Metoprolol; Mouth Diseases; Omeprazole; Oral Hygiene; Proton Pump Inhibitors; Simvastatin; Thyroxine; Toothpastes; Xerostomia	2020
Twice-daily versus once-daily lisinopril and losartan for hypertension: Real-world effectiveness and safety. PloS one, 2020, Volume: 15, Issue:12 Topics: Aged; Aged, 80 and over; Angioedema; Antihypertensive Agents; Blood Pressure; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Hypertension; Lisinopril; Losartan; Male; Middle Aged; Retrospective Studies; Treatment Outcome	2020
Antihypertensive drug treatment and susceptibility to SARS-CoV-2 infection in human PSC-derived cardiomyocytes and primary endothelial cells. Stem cell reports, 2021, 10-12, Volume: 16, Issue:10 Topics: Antihypertensive Agents; Cells, Cultured; COVID-19; COVID-19 Drug Treatment; Disease Susceptibility; Endothelial Cells; Host-Pathogen Interactions; Humans; Lisinopril; Losartan; Myocytes, Cardiac; SARS-CoV-2; Transcriptome	2021
Antihypertensive medicine use differs between Ghana and Nigeria. BMC cardiovascular disorders, 2022, 08-10, Volume: 22, Issue:1 Topics: Amlodipine; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Ghana; Humans; Hypertension; Lisinopril; Losartan; Nifedipine; Nigeria	2022
The ACE Inhibitor Lisinopril Stimulates Melanoma Cell Invasiveness by Inducing MMP2 Secretion. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2022, Sep-05, Volume: 56, Issue:5 Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cyclooxygenase 2; Humans; Lisinopril; Losartan; Matrix Metalloproteinase 2; Melanoma	2022